IRF4 and systemic lupus erythematosus: The ROCK-IRF4 axis may play a broad pathogenic role in lupus since administration of a ROCK inhibitor, Fasudil, ameliorated lupus pathogenesis in two additional mouse models of SLE, MRL/lpr mice and NZB/W F1 mice [29, 31].